我国非小细胞肺癌分子靶向治疗的现实问题及应对建议

Molecular targeted therapy for non-small cell lung cancer:the reality in China and coping strategy

在肺癌领域,分子靶向药物日益影响并改变着肺癌治疗的临床实践。分子靶向治疗使肺癌治疗模式发生了重大改变,但分子靶向治疗也给临床带来了新挑战,为此就肺癌分子靶向治疗的现实问题进行综述,并提出应对建议。

For lung cancer,molecular targeted drugs are increasingly influencing and changing the treatment of lung cancer,molecular targeted therapy makes significant change in lung cancer treatment,but also bring new challenges to clinical doctors.So authors take the reality in China to review relevant literature,and put forward the copying suggestion.